Breakthrough in Lung Cancer: Imfinzi’s FDA Approval for Limited-Stage SCLC Patients
AstraZeneca’s (AZ) Imfinzi (durvalumab) has received approval from the US Food and Drug Administration (FDA) for treating adults…
FDA Approval
INNOVATION VERTE : INSIDE LOOK AT PUNE’S LUPIN RESEARCH PARK R&D FACILITIES
Lupin Limited, a prominent global pharmaceutical company, has announced that its Research and Development facility at the Lupin…
Gland Pharma’s Latanoprost Solution: FDA Approved
Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for its Latanoprost Ophthalmic…
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide
Potential first and only DHE autoinjector for tough-to-treat migraines and cluster headaches Exenatide approval highlights Amneal’s capabilities in…
Ultromics’ breakthrough device for cardiac amyloidosis gets FDA nod
EchoGo® Amyloidosis is an AI-based software-only medical device, which aims to improve early detection of Cardiac Amyloidosis, an…
Indoco Remedies receives final ANDA approval from USFDA for Varenicline Tablets, 0.5 mg and 1 mg
Indoco Remedies Ltd. announced the final approval of the Company’s Abbreviated NewDrug Application (ANDA) for Varenicline Tablets, 0.5…
Amneal Pharma Receives FDA Approval for Propofol Injectable Emulsion in Multiple Doses
Amneal Pharmaceuticals, Inc. announced that it has received Abbreviated New Drug Application (“ANDA”) approval from the U.S. Food…